Header cover image

Global Strong Balance Sheet Stocks

UPDATED May 20, 2022

U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

3,775 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
EPAYBottomline TechnologiesUS$56.990.7%48.0%US$2.6bUS$56.10PS5.1xE56.4%n/aSoftware
AZPNAspen TechnologyUS$166.304.3%17.7%US$11.1bUS$172.43PS40.8xE12.6%n/aSoftware
EXODExodus MovementUS$12.250%n/aUS$309.2mn/aPS13.5xn/an/aSoftware
EXDWExceed WorldUS$1.200%21.2%US$39.2mn/aPS348.8xn/an/aConsumer Services
FSMK1ST SUMMIT BANCORP of JohnstownUS$42.000%n/aUS$92.2mn/aPS11.2xn/a3.9%Banks
MBKLMBT BancsharesUS$25.75-2.8%10.8%US$52.6mn/aPB1.2xn/a3.9%Banks
AIFSAgent Information SoftwareUS$2.150%-0.5%US$10.1mn/aPS7963xn/a1.6%Software
FMFPFirst Community FinancialUS$22.000%n/aUS$62.1mn/aPB1.1xn/a3.2%Banks
PVBKPacific Valley BancorpUS$10.310%-5.0%US$41.5mn/aPS11xn/an/aBanks
PPALPeoples Trust Company of St. AlbansUS$55.000%-43.3%US$31.5mn/aPS14.4xn/a1.7%Banks
WHLTChase PackagingUS$0.08-24.2%-20.0%US$5.0mn/aPB10.5xn/an/aMaterials
OPRAOperaUS$5.23-2.1%-49.7%US$602.2mUS$12.00PS2.2xE127.8%n/aSoftware
HLTHCue HealthUS$5.121.8%n/aUS$755.0mUS$9.88PS22xS9.7%n/aHealthcare
REPLReplimune GroupUS$14.79-0.3%-59.2%US$725.7mUS$47.80PB1.8xE16.4%n/aPharmaceuticals & Biotech
EVGOEVgoUS$9.154.2%-18.4%US$2.4bUS$13.89PS94xE68.2%n/aRetail
IHiHumanUS$2.46-14.0%-75.8%US$131.3mUS$4.10PB1.4xS24.9%n/aMedia
GRPHGraphite BioUS$2.28-12.3%n/aUS$132.2mUS$13.00PS-1.7xE-14.9%n/aPharmaceuticals & Biotech
FBRXForte BiosciencesUS$1.10-6.8%-97.1%US$16.2mn/an/an/an/aPharmaceuticals & Biotech
QFIN360 DigiTechUS$13.865.1%-48.6%US$2.2bUS$25.34PS2.5xE8.4%7.4%Diversified Financials
ANVSAnnovis BioUS$9.15-2.9%-84.8%US$74.7mUS$31.50PB1.8xE-18.9%n/aPharmaceuticals & Biotech
PASGPassage BioUS$2.0210.4%-85.2%US$109.7mUS$13.43n/aE9.3%n/aPharmaceuticals & Biotech
VERVVerve TherapeuticsUS$13.41-2.3%n/aUS$652.5mUS$52.00PB2xE-17.0%n/aPharmaceuticals & Biotech
NRGVEnergy Vault HoldingsUS$11.7411.2%21.9%US$1.6bUS$16.75PS36.6xE94.8%n/aCapital Goods
TALSTalaris TherapeuticsUS$7.3717.9%-44.4%US$305.6mUS$22.50PB1.4xE-14.4%n/aPharmaceuticals & Biotech
Page 1 of 158